{"id":"https://openalex.org/W29166128","doi":"https://doi.org/10.1177/135965350601100703","title":"Lamivudine and Indinavir/Ritonavir Maintenance Therapy in Highly Pretreated HIV-Infected Patients (Vista Anrs 109)","display_name":"Lamivudine and Indinavir/Ritonavir Maintenance Therapy in Highly Pretreated HIV-Infected Patients (Vista Anrs 109)","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W29166128","doi":"https://doi.org/10.1177/135965350601100703","mag":"29166128","pmid":"https://pubmed.ncbi.nlm.nih.gov/17302251"},"language":"en","primary_location":{"id":"doi:10.1177/135965350601100703","doi":"https://doi.org/10.1177/135965350601100703","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350601100703","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350601100703","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350601100703","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"for the ANRS 109 VISTA Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092774","display_name":"H\u00f4pital Cochin","ror":"https://ror.org/00ph8tk69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"for the ANRS 109 VISTA Study Group","raw_affiliation_strings":["Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Descartes; Service de Medecine Interne, Hopital Cochin, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Descartes; Service de Medecine Interne, Hopital Cochin, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069099276","display_name":"Odile Launay","orcid":"https://orcid.org/0000-0003-3242-7247","observed_orcids":["https://orcid.org/0000-0003-3242-7247"]},"institutions":[{"id":"https://openalex.org/I4210092774","display_name":"H\u00f4pital Cochin","ror":"https://ror.org/00ph8tk69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4210124464"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Odile Launay","raw_affiliation_strings":["Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Descartes; Service de Medecine Interne, Hopital Cochin, AP-HP, Paris, France","Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Diderot; Service des Maladies Infectieuses et Tropicales, H\u00f4pital Bichat-Claude Bernard, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Descartes; Service de Medecine Interne, Hopital Cochin, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4387156284"]},{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Diderot; Service des Maladies Infectieuses et Tropicales, H\u00f4pital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102990244","display_name":"Xavier Duval","orcid":"https://orcid.org/0000-0003-1079-4230","observed_orcids":["https://orcid.org/0000-0003-1079-4230"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Xavier Duval","raw_affiliation_strings":["Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Diderot; Service des Maladies Infectieuses et Tropicales, H\u00f4pital Bichat-Claude Bernard, AP-HP, Paris, France","Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Diderot; Service des Maladies Infectieuses et Tropicales, H\u00f4pital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170","https://openalex.org/I4387154366"]},{"raw_affiliation_string":"Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035359860","display_name":"C\u00e9cile Dalban","orcid":"https://orcid.org/0009-0006-3979-7645","observed_orcids":["https://orcid.org/0009-0006-3979-7645"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C\u00e9cile Dalban","raw_affiliation_strings":["Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","Service de Virologie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264447"]},{"raw_affiliation_string":"Service de Virologie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047124634","display_name":"Diane Descamps","orcid":"https://orcid.org/0000-0002-6556-1525","observed_orcids":["https://orcid.org/0000-0002-6556-1525"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Diane Descamps","raw_affiliation_strings":["Service de Virologie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","Pharmacie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Virologie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"raw_affiliation_string":"Pharmacie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061527531","display_name":"Gilles Peytavin","orcid":"https://orcid.org/0000-0002-4359-537X","observed_orcids":["https://orcid.org/0000-0002-4359-537X"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Peytavin","raw_affiliation_strings":["Pharmacie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029188174","display_name":"Agn\u00e8s Certain","orcid":"https://orcid.org/0000-0002-0851-1716","observed_orcids":["https://orcid.org/0000-0002-0851-1716"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Agn\u00e8s Certain","raw_affiliation_strings":["Pharmacie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacie, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"raw_affiliation_string":"Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011904579","display_name":"Sai\u034f\u0308d Mouajjah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sa\u00efd Mouajjah","raw_affiliation_strings":["Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","Service des Maladies Infectieuses et Tropicales, Hopital Bichat-Claude Bernard, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264447"]},{"raw_affiliation_string":"Service des Maladies Infectieuses et Tropicales, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036194439","display_name":"Pascal Ralaimazava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210114068","display_name":"Centre Hospitalier Universitaire de Caen Normandie","ror":"https://ror.org/027arzy69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210114068"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pascal Ralaimazava","raw_affiliation_strings":["Service des Maladies Infectieuses et Tropicales, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","Service des Maladies Infectieuses, CHU de Caen, Caen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des Maladies Infectieuses et Tropicales, Hopital Bichat-Claude Bernard, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"raw_affiliation_string":"Service des Maladies Infectieuses, CHU de Caen, Caen, France","institution_ids":["https://openalex.org/I4210114068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112277277","display_name":"Renaud Verdon","orcid":"https://orcid.org/0000-0001-6277-5504","observed_orcids":["https://orcid.org/0000-0001-6277-5504"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210114068","display_name":"Centre Hospitalier Universitaire de Caen Normandie","ror":"https://ror.org/027arzy69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210114068"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Renaud Verdon","raw_affiliation_strings":["Service des Maladies Infectieuses, CHU de Caen, Caen, France","Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des Maladies Infectieuses, CHU de Caen, Caen, France","institution_ids":["https://openalex.org/I4210114068"]},{"raw_affiliation_string":"Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039272561","display_name":"Dominique G. Costagliola","orcid":"https://orcid.org/0000-0003-0765-0869","observed_orcids":["https://orcid.org/0000-0003-0765-0869"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dominique Costagliola","raw_affiliation_strings":["Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","Inserm U552 Paris, France; Universit\u00e9 Paris-Diderot, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm U720 Paris, France; Universit\u00e9 Pierre et Marie Curie, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405264447"]},{"raw_affiliation_string":"Inserm U552 Paris, France; Universit\u00e9 Paris-Diderot, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154366"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109208581","display_name":"Fran\u00e7ois Clavel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Clavel","raw_affiliation_strings":["Inserm U552 Paris, France; Universit\u00e9 Paris-Diderot, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm U552 Paris, France; Universit\u00e9 Paris-Diderot, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154366"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":0.2055,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.59172728,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"11","issue":"7","first_page":"889","last_page":"900"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.8669999837875366},{"id":"https://openalex.org/keywords/indinavir","display_name":"indinavir","score":0.8429999947547913},{"id":"https://openalex.org/keywords/ritonavir-boosted-protease-inhibitors","display_name":"ritonavir-boosted protease inhibitors","score":0.7979999780654907},{"id":"https://openalex.org/keywords/treatment-simplification","display_name":"treatment simplification","score":0.9089999794960022},{"id":"https://openalex.org/keywords/drug-resistant-hiv","display_name":"drug-resistant HIV","score":0.597000002861023},{"id":"https://openalex.org/keywords/viral-rebound","display_name":"viral rebound","score":0.49000000953674316},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8360000252723694},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.8230000138282776},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7200000286102295},{"id":"https://openalex.org/keywords/immune-reconstitution","display_name":"immune reconstitution","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.8128237724304199},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.7842764854431152},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.7375715374946594},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.715826690196991},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6966113448143005},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.6516098976135254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5961658954620361},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5915923714637756},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.526292622089386},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.47378847002983093},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4142317771911621},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3495407700538635},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.34902143478393555},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3408570885658264},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.24801266193389893},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.17584261298179626},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.14499908685684204},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016333","descriptor_name":"HIV Protease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023381","descriptor_name":"Endpoint Determination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/135965350601100703","doi":"https://doi.org/10.1177/135965350601100703","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350601100703","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350601100703","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:17302251","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17302251","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1177/135965350601100703","doi":"https://doi.org/10.1177/135965350601100703","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350601100703","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350601100703","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320321833","display_name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","ror":"https://ror.org/01kv58h76"},{"id":"https://openalex.org/F4320338463","display_name":"CHIST-ERA","ror":"https://ror.org/00rbzpz17"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W29166128.pdf","grobid_xml":"https://content.openalex.org/works/W29166128.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1480425134","https://openalex.org/W1592830913","https://openalex.org/W1604226439","https://openalex.org/W1606975204","https://openalex.org/W1965538807","https://openalex.org/W1969230234","https://openalex.org/W1980843502","https://openalex.org/W1991518539","https://openalex.org/W1998575185","https://openalex.org/W2032381212","https://openalex.org/W2045953763","https://openalex.org/W2080237955","https://openalex.org/W2084273391","https://openalex.org/W2102133068","https://openalex.org/W2122352032","https://openalex.org/W2131078908","https://openalex.org/W2133011527","https://openalex.org/W2137728388","https://openalex.org/W2158013170","https://openalex.org/W2158842834","https://openalex.org/W2331670444","https://openalex.org/W2465399635"],"related_works":["https://openalex.org/W2009577475","https://openalex.org/W2890795745","https://openalex.org/W2055147541","https://openalex.org/W2126311717","https://openalex.org/W2020342896","https://openalex.org/W7217580230","https://openalex.org/W1974067390","https://openalex.org/W2425971858","https://openalex.org/W2172124176","https://openalex.org/W1999935689"],"abstract_inverted_index":{"OBJECTIVE:":[0],"In":[1,256],"patients":[2,54,137,159,257],"with":[3,62,213,258],"extensive":[4],"HIV":[5,72],"resistance,":[6,38,260],"one":[7],"option":[8],"is":[9],"to":[10,133,208,273],"delay":[11,23],"salvage":[12],"therapy":[13,233],"until":[14],"new":[15],"drugs":[16],"become":[17],"available.":[18],"We":[19],"hypothesized":[20],"that":[21,226],"this":[22],"period":[24],"could":[25],"be":[26],"based":[27],"on":[28],"a":[29,84,112,214],"simplified":[30],"treatment,":[31],"which":[32,221],"would":[33],"reduce":[34],"drug":[35,269],"toxicity,":[36],"stabilize":[37,274],"and":[39,83,102,147,248],"prevent":[40],"resurgence":[41,264],"of":[42,59,218,265,276],"wild-type":[43,266],"virus.":[44],"METHODS:":[45],"A":[46],"prospective":[47],"24-week":[48],"treatment":[49,261],"simplification":[50,262],"study":[51],"in":[52,114,124,182,199,245],"HIV-1-infected":[53],"having":[55],"failed":[56,272],"several":[57],"lines":[58],"antiretroviral":[60,232],"therapy,":[61],"CD4+":[63,115,149,200],"T-cell":[64,116,150,201],"counts":[65,117,202],">":[66,77,118,126],"or":[67,78,119,122,127],"=":[68,79,120,128,164,194],"100":[69],"cells/ml,":[70],"plasma":[71,183],"RNA":[73],"(viral":[74],"load":[75],"[VL])":[76],"4":[80],"log10":[81,145,187],"copies/ml":[82,131,146,188],"resistance":[85],"genotype":[86],"predicting":[87],"less":[88],"than":[89],"two":[90],"active":[91,231],"drugs.":[92],"Treatment":[93],"associated":[94],"ritonavir-boosted":[95],"low-dose":[96],"indinavir":[97],"(200":[98],"mg":[99,105],"twice":[100,106],"daily)":[101],"lamivudine":[103],"(150":[104],"daily).":[107],"The":[108,196],"primary":[109,168],"endpoint":[110],"was":[111,143,152,185,203,222],"decrease":[113],"25%":[121],"increase":[123],"VL":[125,142,184],"0.7":[129],"log":[130],"relative":[132],"baseline.":[134],"RESULTS:":[135],"Twenty-six":[136],"were":[138,241],"included.":[139],"Baseline":[140],"median":[141,148,180,197,215],"4.5":[144],"count":[151],"290":[153],"cells/ml.":[154],"During":[155],"the":[156,167,179,235,253,277],"study,":[157],"10/26":[158],"(38%,":[160],"95%":[161],"confidence":[162],"interval":[163],"20.2-59.4)":[165],"reached":[166],"endpoint.":[169],"No":[170],"patient":[171],"had":[172],"an":[173],"AIDS-defining":[174],"event.":[175],"At":[176],"week":[177],"24,":[178],"change":[181,198],"+0.2":[186],"(interquartile":[189],"range":[190],"(IQR):":[191],"0-0.5;":[192],"P":[193,210],"0.003).":[195],"-49":[204],"cells/ml":[205],"(IQR:":[206],"-14":[207],"-93,":[209],"<":[211],"0.001),":[212],"decline":[216],"slope":[217],"10":[219],"cells/ml/month,":[220],"not":[223],"different":[224],"from":[225],"measured":[227],"under":[228],"full":[229],"highly":[230],"during":[234,252],"6":[236],"months":[237],"preceding":[238],"inclusion.":[239],"There":[240],"no":[242],"significant":[243],"changes":[244],"HIV-1":[246],"protease":[247],"reverse":[249],"transcriptase":[250],"genotypes":[251],"study.":[254],"CONCLUSIONS:":[255],"advanced":[259],"prevented":[263],"HIV,":[267],"reduced":[268],"burden,":[270],"but":[271],"progression":[275],"immune":[278],"deficiency.":[279]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}